PHARMACOTHERAPEUTIC BIOADHESIVE COMPOSITION

USPTO Patent Application US 2017/0196819 A1
Application Date: Jul. 13rd, 2017

ABSTRACT

Embodiments of the claimed invention are directed to a biodegradable mucosal bioadhesive composition that delivers a therapeutic agent specifically to the target site, without loss to saliva or absorption by...
Application Number:
15/402,212
International Classification:
A61K 9/70 (20060101); A61K 9/00 (20060101); A61K 47/34 (20060101); B29C 39/36 (20060101); A61K 47/32 (20060101); A61K 47/36 (20060101); A61K 47/10 (20060101); B29C 39/00 (20060101); A61K 31/573 (20060101); A61K 47/38 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1. A biodegradable mucosal bioadhesive composition comprising polylactic acid, sodium carboxymethyl cellulose, carbopol, chitosan, PEG, and a therapeutic agent.

DESCRIPTION

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of priority to and incorporates by reference the entire disclosure of U.S. Provisional Patent Application No. 62/276,842 filed on Jan. 9, 2016.
Back to Top